BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8075071)

  • 1. Elongation factor Tu D138N, a mutant with modified substrate specificity, as a tool to study energy consumption in protein biosynthesis.
    Weijland A; Parlato G; Parmeggiani A
    Biochemistry; 1994 Sep; 33(35):10711-7. PubMed ID: 8075071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
    Jacquet E; Parmeggiani A
    Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a model for the interaction between elongation factor Tu and the ribosome.
    Weijland A; Parmeggiani A
    Science; 1993 Feb; 259(5099):1311-4. PubMed ID: 8446899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between the GTPase activities of EF-Tu.GTP and EF-G.GTP on empty ribosomes. Elongation factors as stimulators of the ribosomal oscillation between two conformations.
    Mesters JR; Potapov AP; de Graaf JM; Kraal B
    J Mol Biol; 1994 Oct; 242(5):644-54. PubMed ID: 7932721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of histidine-84 in the elongation factor Tu GTPase activity and in poly(Phe) synthesis: its substitution by glutamine and alanine.
    Scarano G; Krab IM; Bocchini V; Parmeggiani A
    FEBS Lett; 1995 May; 365(2-3):214-8. PubMed ID: 7781781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
    Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
    Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of fluoroaluminates on the peptide chain elongation factors EF-Tu and EF-G as members of the GTPase superfamily.
    Mesters JR; Martien de Graaf J; Kraal B
    FEBS Lett; 1993 Apr; 321(2-3):149-52. PubMed ID: 8477844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.
    Vorstenbosch E; Pape T; Rodnina MV; Kraal B; Wintermeyer W
    EMBO J; 1996 Dec; 15(23):6766-74. PubMed ID: 8978702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An A to U transversion at position 1067 of 23 S rRNA from Escherichia coli impairs EF-Tu and EF-G function.
    Saarma U; Remme J; Ehrenberg M; Bilgin N
    J Mol Biol; 1997 Sep; 272(3):327-35. PubMed ID: 9325093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biosynthesis: structural studies of the elongation cycle.
    Nyborg J; Liljas A
    FEBS Lett; 1998 Jun; 430(1-2):95-9. PubMed ID: 9678602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
    Cetin R; Anborgh PH; Cool RH; Parmeggiani A
    Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
    Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
    EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu.
    Swart GW; Parmeggiani A; Kraal B; Bosch L
    Biochemistry; 1987 Apr; 26(7):2047-54. PubMed ID: 3297141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tRNA and the guanosinetriphosphatase activity of elongation factor Tu.
    Swart GW; Parmeggiani A
    Biochemistry; 1989 Jan; 28(1):327-32. PubMed ID: 2539860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
    Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
    EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of elongation factor Tu with the ribosome. A study using the antibiotic kirromycin.
    Sander G; Ivell R; Crechet JB; Parmeggiani A
    Biochemistry; 1980 Mar; 19(5):865-70. PubMed ID: 6101963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.